Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CYP2D6 pharmacogenetics and phenoconversion in personalized medicine
Noor A. Nahid, Julie A. Johnson
Expert Opinion on Drug Metabolism & Toxicology (2022) Vol. 18, Iss. 11, pp. 769-785
Closed Access | Times Cited: 19

Showing 19 citing articles:

Decoding the Role of CYP450 Enzymes in Metabolism and Disease: A Comprehensive Review
Basma Hossam Abdelmonem, Noha M. Abdelaal, Eman K. E. Anwer, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1467-1467
Open Access | Times Cited: 18
In vitro comparative analysis of metabolic capabilities and inhibitory profiles of selected CYP2D6 alleles on tramadol metabolism
Noor Ahmed Nahid, Raju S. Kanumuri, Abhisheak Sharma, et al.
Clinical and Translational Science (2025) Vol. 18, Iss. 2
Open Access | Times Cited: 1
BCyrius: An Upgraded Version of Cyrius for Accurate CYP2D6 Genotyping From Short‐Read Sequencing Data
Andreas Halman, Rachel Conyers
Pharmacology Research & Perspectives (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Influence of CYP2C19 and CYP2D6 on side effects of aripiprazole and risperidone: A systematic review
Emma Y De Brabander, Kristian Kleine Schaars, Thérèse van Amelsvoort, et al.
Journal of Psychiatric Research (2024) Vol. 174, pp. 137-152
Open Access | Times Cited: 5
CYP2D6 genotype and associated 5‐HT3 receptor antagonist outcomes: A systematic review and meta‐analysis
Claire Moore, Elizabeth Williams, Roxanne Dyas, et al.
Clinical and Translational Science (2025) Vol. 18, Iss. 2
Open Access
A Hypothesized Therapeutic Role of (Z)-Endoxifen in Duchenne Muscular Dystrophy (DMD)
H. Lawrence Remmel, Sandra S Hammer, L. Neff, et al.
Degenerative Neurological and Neuromuscular Disease (2025) Vol. Volume 15, pp. 1-15
Open Access
Epigenetic modifications in drug‐induced liver injury: A systematic review
Romina Lorena de los Santos‐Fernández, Antonio Segovia‐Zafra, Guillermo Paz‐López, et al.
British Journal of Clinical Pharmacology (2025)
Closed Access
The pharmacogenetics of CYP2D6 and CYP2C19 in a case series of antidepressant responses
Ping Siu Kee, Simran Maggo, Martin A. Kennedy, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Use of CYP2D6 substrates and inhibitors during pain management with analgesic opioids: Drug-drug interactions that lead to lack of analgesic effectiveness
Javier Muriel, M Escorial, C. Carratalà, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116882-116882
Open Access | Times Cited: 3
The Relevance of Integrating CYP2C19 Phenoconversion Effects into Clinical Pharmacogenetics
Maike Scherf‐Clavel, Heike Weber, Stefan Unterecker, et al.
Pharmacopsychiatry (2024) Vol. 57, Iss. 02, pp. 69-77
Open Access | Times Cited: 2
Precision dosing for patients on tricyclic antidepressants
Zahi Nakad, Yolande Saab
Pharmacogenetics and Genomics (2024)
Closed Access | Times Cited: 1
Interactions between grapefruit juice and psychotropic medications: an update of the literature and an original case series
Marcin Siwek, Anna Julia Krupa, Jarosław Woroń
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 5, pp. 333-345
Closed Access | Times Cited: 1
Use of CYP2D6 Inhibitors with CYP2D6 Opioids: Association with Emergency Department Visits for Pain
Noor Ahmed Nahid, Caitrin W. McDonough, Yu‐Jung Jenny Wei, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 4, pp. 1005-1012
Closed Access | Times Cited: 1
Pharmacogenetics
Pritmohinder S. Gill, Patricia Porter‐Gill, Don Rule, et al.
Elsevier eBooks (2024), pp. 445-456
Closed Access
Catalyzing Pharmacogenomic Analysis for Informing Pain Treatment (C-PAIN): A Randomized Trial of Preemptive CYP2D6 Genotyping in Cancer Palliative Care
Youngwoo Cho, Theodore Karrison, M. Jack, et al.
Journal of Pain Research (2024) Vol. Volume 17, pp. 4187-4196
Open Access
Pharmacogenomic insights in psychiatric care: uncovering novel actionability, allele-specific CYP2D6 copy number variation, and phenoconversion in 15,000 patients
Jai N. Patel, Sarah Morris, Raúl Torres, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 11, pp. 3495-3502
Open Access
Genetic susceptibility and clinical features of CYP2D6 associated with systemic lupus erythematosus in a Chinese population
Xiaoning Luo, Juanhua Du, Jinjun Zhao, et al.
Lupus (2024)
Closed Access
Inhibitory effects characteristics of polysaccharide of Polygonati Rhizome on cytochrome P450 enzymes
Yan Duan, Xiaohong Wang, Ruidong Wang, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
Pharmacogenetic Factors in Pharmacodynamic/Pharmacokinetic (PD/PK) Modulations of Medicines
Mükerrem Betül Yerer
(2023), pp. 163-171
Closed Access | Times Cited: 1
Page 1

Scroll to top